Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy
about
Emerging targets and novel approaches to Ebola virus prophylaxis and treatmentNanocarriers Usage for Drug Delivery in Cancer TherapyRecent Developments of Liposomes as Nanocarriers for Theranostic Applications.The Smart Drug Delivery System and Its Clinical PotentialPotential Effect of Liposomes and Liposome-Encapsulated Botulinum Toxin and Tacrolimus in the Treatment of Bladder DysfunctionAdvances and Challenges of Liposome Assisted Drug DeliveryIntravesical liposome drug delivery and IC/BPSThe potential of liposomes with carbonic anhydrase IX to deliver anticancer ingredients to cancer cells in vivoEngineered nanomaterial uptake and tissue distribution: from cell to organismTreating relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia: liposome-encapsulated vincristineAptamer-Mediated Targeted Delivery of Therapeutics: An UpdateAdvanced Therapeutic Strategies for Chronic Lung Disease Using Nanoparticle-Based Drug DeliveryExploring the tumor microenvironment with nanoparticlesActive targeted drug delivery for microbes using nano-carriersSafety of Nanoparticles in MedicineThe janus facet of nanomaterialsCentral nervous system toxicity of metallic nanoparticlesLiposomes as nanomedical devicesSapC-DOPS nanovesicles as targeted therapy for lung cancerRealizing the clinical potential of cancer nanotechnology by minimizing toxicologic and targeted delivery concernsTransport of nanoparticles and tobramycin-loaded liposomes in Burkholderia cepacia complex biofilmsDevelopment of a cell-based bioassay for phospholipase A2-triggered liposomal drug releaseMagnetic Nanoparticle Facilitated Drug Delivery for Cancer Therapy with Targeted and Image-Guided ApproachesPhotoacoustic imaging of tumor targeting with riboflavin-functionalized theranostic nanocarriers.Clinical Translation of Nanomedicine.Designer lipids for drug delivery: from heads to tails.Fiber-optic triggered release of liposome in vivo: implication of personalized chemotherapy.Delivery of cancer therapeutics using nanotechnologyDiamagnetic chemical exchange saturation transfer (diaCEST) liposomes: physicochemical properties and imaging applicationsPreparation, biodistribution and neurotoxicity of liposomal cisplatin following convection enhanced delivery in normal and F98 glioma bearing rats.Liposomal Encapsulation for Systemic Delivery of Propranolol via Transdermal Iontophoresis Improves Bone Microarchitecture in Ovariectomized RatsBiocompatibility of Liposome Nanocarriers in the Rat Inner Ear After Intratympanic AdministrationLiposomal Formulations in Clinical Use: An Updated Review.Nanoparticle-based drug delivery to the vagina: a review.The baffling human body and the boundless nanomaterial boon-a trap for cancer crab.Future of the particle replication in nonwetting templates (PRINT) technologyBioengineering strategies for designing targeted cancer therapiesA novel hydrolysis-resistant lipophilic folate derivative enables stable delivery of targeted liposomes in vivo.Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in Alzheimer's disease mouse models.Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells.
P2860
Q24597625-21C66657-19B7-45C9-B896-294C1AF82636Q26740048-6F1A9D29-455C-4325-A824-99F89D3E8853Q26744835-283B5946-3686-4DFC-814E-CD46F67A3202Q26744837-2EB0C4AC-3562-4CC0-854F-48D67A6D7C5EQ26752959-E8F0CD4C-CAE4-41C3-BD21-713D7512F841Q26773160-039AAC14-FB81-49AC-A1E7-81006FD0C92DQ26773571-4B03789E-F5B0-4698-AED0-0AA0946965B5Q26827175-F7314729-77D0-4585-AE8C-404EA295A19FQ26861914-5D30F84F-4C20-45C1-A444-99C231CE0055Q27000078-2B658931-3CE4-47FC-86BF-F0DB93EF0EFEQ28066827-BF7DD393-22FA-473D-9262-229E4CE86C72Q28076132-34FCD0F3-6031-45C7-8782-5FAA0514141EQ28082374-C24CF28F-E483-4535-8DFA-F89855C6F4ACQ28082463-8BBF3CF4-DC2D-4081-8E3F-2634D2DF756EQ28083076-E281283B-5001-46B0-B730-701795C4B913Q28083583-E91D0A5C-69C3-4102-A9E2-86361B240DFAQ28084729-53C883B4-7CBC-4507-946D-5F81CB8E5228Q28088315-1E2D1311-CCE8-4BA3-B8DE-14DAAF93CD46Q28387728-F5DFE131-E951-4961-B492-6F61B731DDCEQ28396462-957E89D5-B6B3-4AA4-A90B-8E7325FB08B5Q28535144-E3DC67B7-93A9-4F79-8125-D8D1ED4BB34DQ28547031-047898E5-04F5-4118-ACC5-0A637F05F005Q30354223-4D6BCFB0-9C35-4C0C-AD65-FC2923EF9D29Q30355156-2A830084-41BA-4089-8E53-35AB12F023C4Q30355939-23488C40-F4FA-4588-B21D-B8DFD81A4846Q30402374-BF37FEFF-C03C-4E60-82B7-47B367AB0A0DQ30404334-92990B12-5452-44A6-93EA-3E18CC43A53FQ30446963-1ACB56D9-CB0C-473B-932D-31C89D369E62Q30715520-94EDCE76-DE66-412F-AD07-B0D46E76CDD9Q31106992-013AFC9F-2724-420B-8D99-30B60B539F36Q33624740-1A79FBA0-12AE-44DD-9EFA-9591DC69E6B4Q33729077-543D4712-99F8-45AC-A2C9-6BF07810F9D2Q33850427-CD2CFC5F-6AF6-4799-AB6E-7B550076B728Q34079533-63E5522D-A20C-4679-B42C-B5BCD24D66C8Q34108716-03734E8B-D7B4-4C18-9D98-DEBCCC14978EQ34149094-231C53A7-90D9-4DCA-930D-D225727F157EQ34194191-E7194B90-8FBC-4CE0-8D79-56EE5CC3B470Q34306498-2EFA3FF4-311C-48CA-8773-A1D289650401Q34345682-D4F9E98E-8470-4E82-93BD-6D2269E72A49Q34502573-ED7753D7-46EE-4D15-A9EC-4C15CF275450
P2860
Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Clinical development of liposo ...... tion, and therapeutic efficacy
@ast
Clinical development of liposo ...... tion, and therapeutic efficacy
@en
type
label
Clinical development of liposo ...... tion, and therapeutic efficacy
@ast
Clinical development of liposo ...... tion, and therapeutic efficacy
@en
prefLabel
Clinical development of liposo ...... tion, and therapeutic efficacy
@ast
Clinical development of liposo ...... tion, and therapeutic efficacy
@en
P2860
P356
P1476
Clinical development of liposo ...... tion, and therapeutic efficacy
@en
P2093
Hsin-I Chang
Ming-Kung Yeh
P2860
P356
10.2147/IJN.S26766
P407
P577
2011-12-30T00:00:00Z